18禁黄网站禁片无遮挡图片_99久久久久精品一级毛片_www色色

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":37,"cheight":29,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500727.png","picWidth":40,"picHeight":29,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

聯系電話：0851-33411018（行政部） 0851-88173360（銷售部）股票代碼：SZ 002424

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":550,"cheight":381,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889249.png","picWidth":550,"picHeight":381,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

貴州百靈企業集團制藥股份有限公司

股票代碼：SZ 002424

查看更多最新公告>

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":634,"cheight":56,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500733.png","picWidth":630,"picHeight":56,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

走進百靈

專精于藥 · 專注于人

貴州百靈企業集團制藥股份有限公司（以下簡稱“貴州百靈”）是一家從事苗藥研發、生產、銷售于一體的醫藥上市公司，注冊資本14.112億元，總資產70.59億元，員工6124人。2010年6月，公司在深圳證券交易所成功上市（股票代碼：SZ 002424）。公司明確圍繞“強化公司在苗藥領域的優勢地位，力爭成為中成藥領域具有核心競爭優勢的企業”為戰略發展目標，以實施“科技苗藥、文化苗藥、生態苗藥”為抓手，致力打造擁有大健康全產業鏈的企業集團。

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":365,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889219.png","picWidth":360,"picHeight":129,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889221.png","picWidth":"373","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"藥材基地","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889220.png","picWidth":"363","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"藥材基地","linkKey":"page","linkUrl":"page.html?id=675381845688358","jsonData":{}}}

致力于推動苗藥品種的科研創新

實現傳統苗藥現代化、科技化

持續挖掘和探索苗藥寶庫，以傳承

和發揚民族醫藥文化為企業使命

布局中藥材種植產業，加強道地

藥材保護，助力產業化精準扶貧

科技苗藥

文化苗藥

生態苗藥

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":754,"picHeight":61,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

產品與服務

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":752,"picHeight":61,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

非處方藥
處方藥
大健康產品

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":591,"cheight":57,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500734.png","picWidth":590,"picHeight":57,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

百靈動態

關注百靈了解更多最新資訊

百靈新聞
媒體聚焦

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":264,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.fspxgj.com/displaynews.html?newsId=874761550823445","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/868591519924289.jpeg","picWidth":"278","picHeight":"162","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.fspxgj.com/displaynews.html?newsId=874761550823445","linkUrl":"http://www.fspxgj.com/displaynews.html?newsId=874761550823445","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.fspxgj.com/displaynews.html?newsId=874761550823441","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/868591519924278.jpeg","picWidth":"278","picHeight":"162","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.fspxgj.com/displaynews.html?newsId=874761550823441","linkUrl":"http://www.fspxgj.com/displaynews.html?newsId=874761550823441","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":278,"cheight":162,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.fspxgj.com/displaynews.html?newsId=853704785788942","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/844195510091896.jpeg","picWidth":"278","picHeight":"162","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.fspxgj.com/displaynews.html?newsId=853704785788942","linkUrl":"http://www.fspxgj.com/displaynews.html?newsId=853704785788942","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":300,"cheight":164,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.fspxgj.com/displaynews.html?newsId=829425218224198","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/844195350708265.jpeg","picWidth":"278","picHeight":"162","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.fspxgj.com/displaynews.html?newsId=829425218224198","linkUrl":"http://www.fspxgj.com/displaynews.html?newsId=829425218224198","jsonData":{}}}

貴州省副省長董家祿赴貴州百靈調研強調多措并舉培育壯大市場主體

貴州省委副書記、省長李炳軍視察貴州百靈勉勵公司聚焦主業實現可持續發展

貴州省委書記諶貽琴視察貴州百靈勉勵企業搶抓機遇做大做強

捷報！貴州百靈參股子公司賾靈生物在研新藥再獲臨床批件

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"20","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":22,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":21,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"21","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2022-06-09

2022-05-31

2022-05-12

2022-04-28

5月11日，貴州省委書記、省人大常委會主任諶貽琴赴貴州百靈企業集團視察并在安順市宣講省第十三次黨代會精神。諶貽琴書記在貴州百靈視察時強調…詳細>

4月26日，貴州百靈參股子公司成都賾靈生物醫藥科技有限公司收到國家藥品監督管理局核準簽發的《藥物臨床試驗批準通知書》，賾靈生物在研品種1類創新藥ZL-82獲批臨床…詳細>

5月30日，貴州省委副書記、省長李炳軍赴貴州百靈企業集團視察，調研企業生產經營、紓困惠企政策落實和穩崗就業情況等...詳細>

6月8日，貴州省副省長董家祿率隊赴貴州百靈企業集團調研，實地察看生產車間，詳細了解企業在生產經營、市場拓展、產品研發、帶動就業等方面的情況...詳細>

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.fspxgj.com/displaynews.html?newsId=944654853865590","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399231570033.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.fspxgj.com/displaynews.html?newsId=944654853865590","linkUrl":"http://www.fspxgj.com/displaynews.html?newsId=944654853865590","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":267,"cheight":163,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.fspxgj.com/displaynews.html?newsId=944654837088361","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399055409194.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.fspxgj.com/displaynews.html?newsId=944654837088361","linkUrl":"http://www.fspxgj.com/displaynews.html?newsId=944654837088361","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":242,"cheight":162,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"中國證券報 | 貴州百靈：甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399231570022.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"中國證券報 | 貴州百靈：甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床","linkUrl":"中國證券報 | 貴州百靈：甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":268,"cheight":163,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.fspxgj.com/displaynews.html?newsId=829425218224208","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/844195342319657.jpeg","picWidth":268,"picHeight":163,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.fspxgj.com/displaynews.html?newsId=829425218224208","linkUrl":"http://www.fspxgj.com/displaynews.html?newsId=829425218224208","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2022-09-23

2022-09-15

2022-09-03

2022-03-30

為進一步支援西藏地區疫情防控工作，9月6日以來，貴州百靈企業集團千里馳援，向西藏拉薩市、日喀則市等疫情較為嚴重的地區分批捐贈防疫藥品…詳細>

連日來，位于安順經開區的貴州百靈集團，在抓深走實疫情防控的同時，生產機器“火力全開”，努力做好市場需求保障。掃碼、消毒、換工作服裝…詳細>

貴州百靈近日公告稱，公司參股子公司成都賾靈生物醫藥科技有限公司（簡稱“賾靈生物”）于近日收到《四川大學華西醫院臨床試驗倫理審查委員會批件》，同意…詳細>

3月29日晚間，國務院辦公廳印發關于《“十四五”中醫藥發展規劃》（下稱《規劃》）的通知...詳細>

證券日報 | 貴州百靈向西藏捐贈價值280萬元“咳速停糖漿”

貴州日報天眼新聞 | 貴州百靈集團：疫情防控不放松，企業生產不誤時

中國證券報 | 貴州百靈：甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進…

21世紀經濟報道 | “十四五”中醫藥發展規劃落地：建設優質高效中醫藥服務體系....

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":751,"cheight":64,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889216.png","picWidth":751,"picHeight":64,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

投資者關系

與您共享貴州百靈的發展和成績

關注我們

掃一掃關注公眾號

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":96,"cheight":98,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889260.png","picWidth":100,"picHeight":98,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":1220,"cheight":39,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889261.webp","picWidth":1220,"picHeight":39,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

聯系我們

聯系電話：

0851-33411018（行政部）

0851-88173360（銷售部）　

地址：貴州省安順市經濟技術

開發區西航大道　

傳真：0851-33411559

走進百靈

產品與服務

新聞中心

投資者關系

職業發展

責任與公益